Chester County News and Community Website
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that its discovery engine …
Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced the release of findings from …
Read More
The U.S. Food and Drug Administration recently approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded …
Read More
Since the coronavirus (COVID-19) was first reported from Wuhan, China, in December 2019, the disease has been a dominating headline in media around the world.
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. …
Read More
CHEYNEY, PA — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announced the opening of its R&D operations at the Cheyney University science center …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced the initiation of a phase 2 trial, ILLUMINATE-206 which will evaluate tilsotolimod, a toll-like receptor 9 (TLR9) agonist, in combination with nivolumab, a …
Read More
Late summer/early fall is the height of ragweed season. When you add in exposure to environmental factors found in school classrooms, playing fields and eating areas, you have the perfect …
Read More